What is it about?

Antiretroviral therapy has improved survival in persons with HIV (PWH), but chronic obstructive pulmonary disease (COPD) still causes morbidity and mortality. We discovered a novel association of oral microbiome to lung function and to systemic inflammation in PWH, suggesting that the oral microbiome may contribute to COPD pathogenesis.

Featured Image

Read the Original

This page is a summary of: Alterations in Oral Microbiota in HIV are Related to Decreased Pulmonary Function, American Journal of Respiratory and Critical Care Medicine, November 2019, American Thoracic Society, DOI: 10.1164/rccm.201905-1016oc.
You can read the full text:

Read

Contributors

The following have contributed to this page